Seeking Alpha article on PFE’s pipeline completely omits Eliquis, which is almost certainly the most consequential drug in PFE’s pipeline despite the 50/50 profit split with BMY: http://seekingalpha.com/article/942191-could-tofacitinib-save-pfizer LOL